Corporate Management Information Main Article
U.S.-based Daiichi Sankyo Leaders
Our leadership team inspires and challenges every aspect of the organization to develop life-changing solutions for the patients of today and tomorrow. Along with their peers who sit overseas, this dynamic and experienced group of U.S.-based leaders enable us to create innovative medicines that can change the standard of care.
Corporate Management Bio
Corporate Management
Global Oncology Business (U.S.-based leaders)
Ken Keller
Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business
Research & Development (U.S.-based leaders)
U.S. Oncology Business
Other U.S.-based leaders
James Felix
Head of Global Digital Transformation (DX), Chief Digital Transformation Officer
Daiichi Sankyo, Inc. Board of Directors
Daiichi Sankyo, Inc. Board of Directors
Daiichi Sankyo, Inc. Board of Directors
| Chairman of the Board, Corporate President & CEO | Ken Keller |
|---|---|
| Director | Dick Van Duyne |
| Director, Global Head of R&D | Ken Takeshita |
| Director, Head of US Oncology Business Div. | Dan Switzer |
| Director (Independent) | Hiroyuki Fujita*1 |
1 Hiroyuki Fujita is the Chairman of Canon Healthcare USA, INC. etc.
To view the Board of Directors of our parent company, Daiichi Sankyo Co., LTD., visit: https://www.daiichisankyo.com/about_us/mission-strength/leadership/
Last Updated: June 2025